daunorubicin has been researched along with Hypertension in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garg, B; Jain, S; Kapoor, G; Malhotra, P | 1 |
| Lightbody, IM | 1 |
| Ballard, ET; Huang, FS; Stern, LE; Warner, BW; Zwerdling, T | 1 |
| Kuhn, E; Mono, G | 1 |
1 review(s) available for daunorubicin and Hypertension
| Article | Year |
|---|---|
[Cardiotoxic effects of drugs and various other substances. A review].
Topics: Adrenergic Agonists; Amphetamine; Antimony; Arrhythmias, Cardiac; Arsenic Poisoning; Catecholamines; Chloroquine; Clofibrate; Cyclophosphamide; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Emetine; Endomyocardial Fibrosis; Heart; Heart Arrest; Heart Block; Humans; Hypertension; Lithium; Methysergide; Myocarditis; Myofibrils; Psychotropic Drugs | 1978 |
3 other study(ies) available for daunorubicin and Hypertension
| Article | Year |
|---|---|
Incidence and Risk Factors for Hypertension During Childhood Acute Lymphoblastic Leukemia Therapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; Female; Humans; Hypertension; Incidence; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retrospective Studies; Risk Factors; Vincristine | 2018 |
Cardiovascular side effects of non-cardiovascular drugs.
Topics: Aged; Anti-Inflammatory Agents; Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; Cardiomyopathies; Daunorubicin; Hemodynamics; Humans; Hypertension; Lithium; Phenothiazines; Sympathomimetics; Water-Electrolyte Imbalance | 1980 |
Renal cell carcinoma as a secondary malignancy after treatment of acute promyelocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cerebral Infarction; Child; Chromosomes, Human, Pair 17; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Humans; Hypertension; Kidney Failure, Chronic; Leukemia, Promyelocytic, Acute; Male; Neoplasms, Second Primary; Obesity; Remission Induction; Thioguanine | 2001 |